Modelling secondary cancer risk from photon and proton therapy in medulloblastoma
<p>More than half of cancer patients receive radiotherapy for radical or palliative purposes. Increasing survival rates in cancer patients makes it important to study long-term side effects, especially secondary cancers. Medulloblastoma (MB), a posterior fossa tumour, predominantly a childhood...
Main Author: | Madkhali, A |
---|---|
Other Authors: | Partridge, M |
Format: | Thesis |
Language: | English |
Published: |
2018
|
Subjects: |
Similar Items
-
Targeting the PI3K/mTOR and ATR/Chk1 pathways to improve radiation efficacy for cancer therapy
by: Fokas, E
Published: (2012) -
Towards Achieving the Full Clinical Potential of Proton Therapy by Inclusion of LET and RBE Models
by: Bleddyn Jones
Published: (2015-03-01) -
Auger electron radionuclide therapy utilising F3 peptide to target the nucleolus
by: Hillyar, C
Published: (2015) -
TOPK as a novel determinant of radiosensitivity
by: Pirovano, GM
Published: (2016) -
Clinical Progress in Proton Radiotherapy: Biological Unknowns
by: Laura Vanderwaeren, et al.
Published: (2021-02-01)